All episodes

6.Equipments:sec.4-3of12-CVP-normal waveform

6.Equipments:sec.4-2of12-CVP:placement

6.Equipments:sec.4-1of12-BP measurement

6.Equipments:sec.3-9of9-Measurement of Exhaled Gases

6.Equipments:sec.3-8of9-pulse ox limitation

6.Equipments:sec.3-7of9-Pulse oximetry

6.Equipments:sec.3-6of9-Pulse ox relation to oxyhgb curve

6.Equipments:sec.3-5of9-Pulse Oximeter

6.Equipments:sec.3-4of9-Causes of high & low ETCO2

6.Equipments:sec.3-3of9-Capnograph abnormal waveform

6.Equipments:sec.3-2of9-Capnography Waveform

6.Equipments:sec.3-1of9-Assessment of pulmonary resistance a

6.Equipmemts:sec.2-4of4-Bain system

6.Equipments:sec2-3of4-Mapleson Circuit

6.Equipments:sec2:2of4-Circle System

6.Equipments:sec.2-1of4-Classification of breathing circuits

6.Equipments:sec.1-26of26-OSHA RECOMMENDATION regarding inha

6.Equipments:sec.1-25of26-Scavenger system

6.Equipments:sec.1-24of26-High pressure alarm

6.Equipments:sec.1-23of26-Low pressure alarm

6.Equipments:sec.1-22of26-Amsorb plus

6.Equipments:sec.1-21of26-Soda Lime

6.Equipments:sec.1-20of26-Mechanical Ventilation

6.Equipments:sec.1-19of26-VCV vs PCV

6.Equipments:sec.1-18of26-Piston Ventilator

6.Equipments:sec.1-17of26-Pneumatic Bellows

6.Equipments:sec.1-16of26-Oxygen flush valve & ventilatory s

6.Equipmets:sec.1-15of27-Oxygen pipeline supply failure

6.Equipments:sec.1-14of26-Oxygen analyzer

6.Equipments:sec.1-13of26-Tec 6 Desflurane Vaporizer

6.Equipments:sec.1-12of26-Variable Bypass Vaporizer:Overview

6.Equipments:sec.1-11of26-Circuit Compliance

6.Equipments:sec.1-10of26-Fresh Gas Coupling

9.Equipments:sec.1-9of26-Flowmeter FiO2 calculation

6.Equipments:sec.1-8of26-Flowmeters & Reynolds Number

6.Equipments:sec.1-7of26-Hypoxia prevention safety device

6.Equipments:sec.1-6of26-Failsafe device

6.Equipments:sec.1-5of26-Safe Handling of Gas Cylinders

6.Equipments:sec.1-4of26-Gas Cylinder

6.Equipments:sec.1-3of26-DISS & PISS

6.Equipments:sec.1-2of26-The SPDD Model

6.Equipment:sec.1-1of26-The anesthesia Machine

5.Pharmacology2:sec.4:11of11-Antagonist

5.Pharmacology2:sec.4-10of11-Partial agonist

5.Pharmacology2:sec.4-9of11-skeletal muscle rigidity

5.Pharmacology2:sec.4-8of11-Methadone

5.Pharmacology2:sec4-7of11-Remifentanil

5.Pharmacology2:sec.4-6of11-Alfentanil

5.Pharmacology2:sec.4-5of11-Meperidine

5.Pharmacology2:sec.4-4of11-Metabolism

5.Pharmacologu2:sec.2-3of11-Relative potency and dependence

5.Pharmacology2:sec.4-2of11-systemic effects

5.Pharmacology2:sec.4-1of11-MOA pain

5.Pharmacology2:sec.2-5of5-Sugammadex

5.Pharmacology2:sec.2-4of5-Muscarinic Antagonists:side effec

5.Pharmacology2:sec3-3of5-Cholinergic side effects

5.Pharmacology2:sec.3-2of5-Pharmacokinetic Neostigmine

5.Pharmacology2:sec.3-1of5-AchE inhibitors:MOA

5.Pharmacology2:sec.2-17of17-Anaphylaxis & NMB

5.Pharmacology2:sec.2-16of17-CV effects of NMB

5.Pharmacology2:sec.2:15of17-Factors that potentiate NM bloc

5.Pharmacology2:sec.2-14of17-Metabolism of Nondepolarizers

5.Pharmacology2:sec.2-13of17-Potency

5.Pharmacology2:sec.2-12of17-Diseases with altered responses

5.Pharmacology2:sec.2-11of17-Post-op myalgia with sux

5.Pharmacology2:sec.2-10of17-Sux Black Box warning

5.Pharmacology2:sec.2-9of17-Dibucaine Test

5.Pharmacology2:sec.2-8of17-Factors that reduce pseudocholin

5.Pharmacology2:sec.2-7of17-Synonym for pseudocholinesterase

5.Pharmacology2:sec.2-6of17-Succinylcholine side effects

5.Pharmacology2:sec.-5of17-Testing recovery from NM blockade

5.Pharmacology2:sec.2-4of17-Phase1 vs Phase 2 block

5.Pharmacology2:sec.2-3of17-Mechanism of fade

5.Pharmacology2:sec.2-2of17-Extrajunctional Receptors

5.Pharmacology2:sec.2-1of17-Neuromuscular Junction Physiolog

5.Pharmacology2:sec.1-15of15-Additives

5.Pharmacology2:sec.1-14of15-Emla Cream

5.Pharmacology2:sec.1-13of15-Methemoglobinemia

5.Pharmacology2:sec.1-12of15-Tumescent Anesthesia

5.Pharmacology2:sec.1-11of15- Treatment for LAST

5.Pharmacology2:sec.1-10-15-LAST

5.Pharmacology2:sec.1-9of10-Maximum allowable dose

5.Pharmacology2:sec.1-8of15-uptake & termination of action

5.Pharmacology2:sec.1-7of15-Acid base chemistry

5.Pharmacology2:sec.1-6of15-onset, potency, Duration of Acti

5.Pharmacology2:sec.1-5of15-Esters & Amides

5.Pharmacology2:sec1-4of15-MOA

5.Pharmacology2:sec.3of15-The action potential & effect ofLA

5.Pharmacology2:sec.1-2of15-voltage gated sodium channel

5.Pharmacology2.:sec.1-1of15-Peripheral Nerves

4.Pharmacology1:sec.5-11of11-Evoked Potential Monitoring

4.Pharmacology1:sec.5-10of11-Neurophysiologic effects

4.Pharmacology1:sec.4-9of11-Pulmonary effects:PaO2

4.Pharmacology1:sec.5-8of11-Pulmonary effects:PaCO2

4.Pharmacology1:sec.4-7of11-Cardiovascular effects

4.Pharmacology1:sec5:6of11-site of anesthetic action

4.Pharmacology1:sec.5-5of11-MOA:New way of Thinking

4.Pharmacology1:sec.5-4of11-MOA-old way of thinking

4.Pharmacology1:sec.5-3of11-MAc:Factors that affect Potency

4.Pharmacology1:sec.5-2of11-MAC